Skip to main content
. 2017 Jan 18;8(12):20462–20475. doi: 10.18632/oncotarget.14726

Table 1. Roles and function mechanisms of lncRNAs in osteosarcoma.

LncRNA Expression Role of lncRNA Function mechanism Reference
TUG1 promotes cell proliferation, inhibits apoptosis, inhibits G0/G1 cell cycle arrest sponges miR-9-5p:downregulates POU2F1 expression [29, 4951, 87]
associated with tumor size, clinical stage and post-operative chemotherapy downregulates POU2F1 expression
correlated with poor prognosis and disease status
an independent prognostic indicator for overall survival
HOTAIR promotes cell proliferation, invasion and secrection of MMP2 and MMP9 [62, 67, 68]
MALAT1 promotes cell proliferation and meatastasis activates PI3K/AKT signaling pathway; [5356]
involvement of RhoA/ROCK Pathway
MALAT1/MIR376A/TGFA axis
regulated by Myc-6
H19 promotes cell proliferation, inhibites apoptosis interacts with miR-141 [60, 61]
induces osteosarcoma development involvement of Hedgehog signaling
HULC correlated with clinical stage, and distant metastasis, but not in another study [78, 79]
correlated with shorter overall survival
SNHG12 promotes cell proliferation and migration upregulates angiomotin gene expression [45]
MFI2 promotes cell proliferation, suppresses apoptosis upregulates FOXP4 expression [46]
PACER promotes cell proliferation and metastasis activates COX-2 gene in a NFκB-dependent way [47]
BCAR4 correlated with large tumor size, advanced Enneking stage, lung metastasis, activates GLI2-dependent gene transcription [80]
and poor prognosis
HNF1A-AS1 associated with clinical stage, distant metastasis, and poor overall survival activates Wnt/β-catenin signaling pathway [44]
BANCR associated with large tumor size, distant metastasis, and advanced clinical stage [27, 86, 110]
an independent predictor of poor survival
UCA1 correlated with large tumor size, high tumor grade, distant metastasis, [81]
and advanced clinical stage
an independent unfavorable prognostic factor
91H correlated with advanced clinical stage, chemotherapy after surgery, [88]
and tumor size >5 cm
an independent prognostic factor for overall survival
ODRUL contributes to doxorubicin resistance induces multidrug resistance-related ABCB1expression [77]
HOTTIP correlated with advanced clinical stage, distant metastasis and poor prognosis interacts with WDR5/MLL complex [83, 108, 109]
increases cisplatin resistance activates Wnt/β-catenin signaling pathway
FOXC2-AS1 influences tumor angiogenesis and metastasis upregulates ABCB1, HIF1A and FOXC2 expression [20]
associated with poor chemoresponse and longer survival time
contributes to doxorubicin resistance
LINC00161 increases cisplatin-induced apoptosis sponges endogenous miR-645 [107]
reverses cisplatin resistance upregulates IFIT2
ZEB1-AS1 promotes cell proliferation and migration binds and recruits p300 to the ZEB1 promoter region, [48]
correlated with large tumor size, progressed Enneking stage, tumor metastasis, activates ZEB1 transcription
worse recurrence-free and overall survival
loc285194 promotes cell growth induced by p53,interact with miR-211 [70, 71]
MEG3 associated with poor overall survival positively regulates p53 expression [84, 85]
TUSC7 promotes cell proliferation and increases colony formation in vitro [43]
HIF2PUT promotes cell proliferation and migration positively correlated with HIF-2α expression [94]
decreases the percentage of CD133 expressing cells
impaires the osteosarcoma stem sphere-forming ability of the MG63 cells